Cronos Group Inc (CRON) has potential to be a cannabis winner
Cronos Group Inc (CRON) currently trades at $5.92 and has grown by 2.16% today. CRON went up $0.12 from the previous closing price of $17.86. The high forecast for Cronos Group Inc is $12.00 and the low is $4.00. The company’s market cap is $2.05 billion with a 52 week high of $17.86 and a 52 week low of $4.00. CRON has changed in price by -9.87 per share in the last 12 months.
Cronos Group Inc has a strong EPS of 3.33. This means the company made $3.33 per share after paying dividends, this can indicate that the stock is a safe investment. EPS is calculated as a company’s profit divided by the outstanding shares of its common stock. The resulting number serves as an indicator of a company’s profitability. It is common for a company to report EPS that is adjusted for extraordinary items and potential share dilution. Based on this information, investorsQ rates this stock 5 out of 10. We give it this rating based on current information written in this article.
About Cronos Group Inc:
With international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group’s portfolio includes PEACE NATURALS™, a global wellness platform, two adult-use brands, COVE™ and Spinach™, and two hemp-derived CBD brands, Lord Jones™ and PEACE+™.